These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 7867758
1. The effects of haloperidol on dopamine receptor gene expression. Fox CA, Mansour A, Watson SJ. Exp Neurol; 1994 Dec; 130(2):288-303. PubMed ID: 7867758 [Abstract] [Full Text] [Related]
2. Dopamine receptor mRNA expression patterns by opioid peptide cells in the nucleus accumbens of the rat: a double in situ hybridization study. Curran EJ, Watson SJ. J Comp Neurol; 1995 Oct 09; 361(1):57-76. PubMed ID: 8550882 [Abstract] [Full Text] [Related]
3. D1 and D2 dopamine receptor gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. Le Moine C, Bloch B. J Comp Neurol; 1995 May 08; 355(3):418-26. PubMed ID: 7636023 [Abstract] [Full Text] [Related]
4. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate-putamen and nucleus accumbens of the rat. Mijnster MJ, Schotte A, Docter GJ, Voorn P. Synapse; 1998 Apr 08; 28(4):302-12. PubMed ID: 9517839 [Abstract] [Full Text] [Related]
5. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum. Aubert I, Ghorayeb I, Normand E, Bloch B. J Comp Neurol; 2000 Feb 28; 418(1):22-32. PubMed ID: 10701753 [Abstract] [Full Text] [Related]
13. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry. Szele FG, Artymyshyn R, Molinoff PB, Chesselet MF. Anat Rec; 1991 Dec 28; 231(4):548-58. PubMed ID: 1838906 [Abstract] [Full Text] [Related]
14. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390. Yu J, Coirini H, Källström L, Wiesel FA, Johnson AE. Synapse; 1998 Sep 28; 30(1):38-48. PubMed ID: 9704879 [Abstract] [Full Text] [Related]
15. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study. Morissette M, Lévesque D, Di Paolo T. Mol Pharmacol; 1992 Sep 28; 42(3):480-8. PubMed ID: 1357544 [Abstract] [Full Text] [Related]
17. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies. Hu XT, White FJ. Synapse; 1994 May 28; 17(1):43-61. PubMed ID: 7913772 [Abstract] [Full Text] [Related]
18. Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system. Humpel C, Knaus GA, Auer B, Knaus HG, Haring C, Theodorsson E, Saria A. Synapse; 1990 May 28; 6(1):1-9. PubMed ID: 1697986 [Abstract] [Full Text] [Related]
19. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum. Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D. Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244 [Abstract] [Full Text] [Related]
20. Regulation of striatal dopamine receptors by estrogen. Lammers CH, D'Souza U, Qin ZH, Lee SH, Yajima S, Mouradian MM. Synapse; 1999 Dec 12; 34(3):222-7. PubMed ID: 10523759 [Abstract] [Full Text] [Related] Page: [Next] [New Search]